Naoki Fujita, Shumon Kato, Yohei Kawashima, Masanao Shinohara, Ryuji Tabata, Ryuma Tanaka, Fumiya Yoneyama, Shingo Hatakeyama. "Efficacy, safety, and cost-effectiveness of reduced vs. full initial dose androgen receptor signaling inhibitors in non-metastatic castration-resistant prostate cancer: A multicenter retrospective study.." Journal of Clinical Oncology (2026). https://doi.org/10.1200/jco.2026.44.7_suppl.371